These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20305539)

  • 21. Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors.
    Chao H; Monahan PE; Liu Y; Samulski RJ; Walsh CE
    Mol Ther; 2001 Sep; 4(3):217-22. PubMed ID: 11545612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of a consanguineous pedigree featuring hereditary coagulation factor Ⅴ deficiency].
    Xie YS; Zhang Y; Zhu LQ; Jin YH; Yang LH; Xie HX; Wang MS; Yang XL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):161-4. PubMed ID: 23568726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A common G10430A mutation (Gly 60 Ser) in the factor IX gene describes the presence of moderate and mild hemophilia B in the majority of the Gujarati population.
    Quadros L; Ghosh K; Shetty S
    Ann Hematol; 2007 May; 86(5):377-9. PubMed ID: 17308903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acquired haemophilia B: a case report and literature review].
    Jedidi I; Hdiji S; Ajmi N; Makni F; Masmoudi S; Elloumi M; Kallel C
    Ann Biol Clin (Paris); 2011; 69(6):685-8. PubMed ID: 22123568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
    Brooks MB; Gu W; Ray K
    J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First case report of hemophilia B Leyden in Japan.
    Yamashita A; Nagae C; Mori M; Ashikaga T; Kojima T; Taki M
    Int J Hematol; 2017 Jul; 106(1):135-137. PubMed ID: 28168417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemophilia B is a quasi-quantitative condition with certain mutations showing phenotypic plasticity.
    Chavali S; Ghosh S; Bharadwaj D
    Genomics; 2009 Dec; 94(6):433-7. PubMed ID: 19699296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of recombinant factor IX and thromboelastography in a patient with hemophilia B undergoing liver transplantation: a case report.
    De Pietri L; Masetti M; Montalti R; Begliomini B; Reggiani A; Barbieri E; Biagioni E; Marietta M; Romano A; Pasetto A; Gerunda GE
    Transplant Proc; 2008; 40(6):2077-9. PubMed ID: 18675136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats].
    Deniz A; Mischke R; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):206-8. PubMed ID: 8593777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one-stage clotting assays.
    Horn C; Négrier C; Kalina U; Seifert W; Friedman KD
    J Thromb Haemost; 2019 Jan; 17(1):138-148. PubMed ID: 30418692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Female twins with severe Christmas disease (hemophilia B).
    Wollina K; Bowen DJ; Syrbe G; Zintl F
    Thromb Haemost; 1993 Nov; 70(5):774-6. PubMed ID: 7907444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurence of haemophilia A and B in a Chinese family with mosaicism of the F9 gene mutation in the HB index's maternal grandfather.
    Lu Y; Xie B; Ding Q; Dai J; Xi X; Wang M; Wang H; Wang X
    Thromb Haemost; 2010 May; 103(5):1106-8. PubMed ID: 20174753
    [No Abstract]   [Full Text] [Related]  

  • 33. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
    Bowyer A; Smith J; Woolley AM; Kitchen S; Hampton KK; Maclean RM; VAN Veen JJ; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
    Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G
    J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of carrier status of hemophilia B using DNA markers.
    Ishak R; Zakaria Z
    Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):629-30. PubMed ID: 9561621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of factor IX mutations in Iranian haemophilia B patients by SSCP and sequencing.
    Karimipoor M; Zeinali S; Nafissi N; Tuddenham EG; Lak M; Safaee R
    Thromb Res; 2007; 120(1):135-9. PubMed ID: 17014892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular analysis of factor IX gene in an Iranian female with severe hemophilia B.
    Karimipoor M; Kokabee L; Kamali E; Karizi SZ; Zeinali S
    Acta Haematol; 2008; 119(3):151-3. PubMed ID: 18434706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal low-level somatic mosaicism of Cys155Tyr of F9 in severe hemophilia B.
    Kim HJ; Lee KO; Yoo KY; Kim SH; Kim HJ
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):866-8. PubMed ID: 25402191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.